Annual Securities Report — FY2025
What Niitaka Co., Ltd. reported for the period from 2025-06-01 to 2026-05-31. Filed by 株式会社ニイタカ
Filed 2026-08-26View the original on EDINET
How much it says
61Detailed
What moved here
13named for the first time
Its own wording
61terms
Which filing this is
37/ 37newest
No officer data yetThis company's filings have not been read for officers yet. Nothing is missing from the filings — the roster simply has not been extracted.
The gist
In the consolidated fiscal year ended 31 May 2026 (1 June 2025 to 31 May 2026), net sales increased, but the Healthcare Business reported lower sales and lower profit. The filing also describes the transfer of all shares in N Business, as well as capital investment and R&D activities, including the renewal of the core systems (R&D expenses of ¥304 million and capital investment of ¥529 million).
Komori's summary of this document, not the document's own words.61Detailed
How much this filing saysA weighted roll-up of 11 rubric dimensions, each scored from a fixed set of questions asked against this filing — built only from the 37 this document could answer. It measures how specific the disclosure is, not whether the company is doing well. Derived from the data, not editorial.
96
Very detailed
68
Detailed
33
Thin
75
Very detailed
100
Very detailed
0
Almost nothing
23
Almost nothing
62
Detailed
60
Detailed
79
Very detailed
73
Detailed
R&D spend3億円Money spent making new things.
Cash left over27億円Cash from the business, less what went into equipment.
Spent on equipment5億円Plants, machines — things meant to last.
Employees380Headcount at the end of this period.
How to read this page
This is not the documentIt is Komori's reading of the filing submitted to EDINET. The original is linked above.
The score is not a verdictIt measures how specific the disclosure is. It says nothing about results or where the share price goes.
When it updatesContent lands once the filing has been read through. Right after submission, the summary can still be empty.